"Renalism" with Renin Angiotensin Aldosterone System Inhibitor use in Patients Enrolled in Trials for Heart Failure with Reduced Ejection Fraction and Advanced Chronic Kidney Disease: A Systematic Review.
Hussein Al SudaniSamir ShahKevin Bryan LoHani EssaAmmaar WattooLucas AngelimSophia BrousasIsabel Whybrow-HuppatzShaitalya VellankiRajiv SankaranarayananJanani RangaswamiPublished in: Current vascular pharmacology (2023)
In the past 10 years, CKD grades 4-5 patients have been increasingly included in HFrEF clinical trials. Concurrently, ACEI/ARB use has reportedly decreased.